Get the Stockscreener App
27.72
2.06%
0.56
Pre-market:
27.29
-0.43
-1.55%
Moderna Inc stock is traded at $27.72, with a volume of 11.73M.
It is up +2.06% in the last 24 hours and down -10.47% over the past month.
See More
Previous Close:
$27.16
Open:
$26.79
24h Volume:
11.73M
Relative Volume:
1.07
Market Cap:
$10.50B
Revenue:
$5.06B
Net Income/Loss:
$-2.22B
P/E Ratio:
-4.7629
EPS:
-5.82
Net Cash Flow:
$-3.96B
1W Performance:
-11.94%
1M Performance:
-10.47%
6M Performance:
-56.11%
1Y Performance:
-73.25%
1-Day Range:
$26.26
$28.78
1-Week Range:
$26.26
$32.57
52-Week Range:
$26.26
$170.47
Moderna Inc Stock (MRNA) Company Profile
Name
Moderna Inc
Sector
Industry
Phone
(617) 714-6500
Address
325 BINNEY STREET, CAMBRIDGE
Compare MRNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
27.72 | 10.50B | 5.06B | -2.22B | -3.96B | -5.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Initiated | Citigroup | Neutral |
| Feb-18-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-29-25 | Downgrade | Goldman | Buy → Neutral |
| Dec-18-24 | Downgrade | Argus | Buy → Hold |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-19-24 | Initiated | Berenberg | Hold |
| Nov-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Sep-13-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-13-24 | Downgrade | Jefferies | Buy → Hold |
| Sep-13-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-24 | Upgrade | HSBC Securities | Reduce → Hold |
| Aug-07-24 | Upgrade | Deutsche Bank | Sell → Hold |
| Aug-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-26-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Jan-02-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-29-23 | Initiated | Canaccord Genuity | Hold |
| Nov-03-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-02-23 | Downgrade | Deutsche Bank | Hold → Sell |
| Aug-04-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Aug-03-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-24-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Reduce |
| Jun-26-23 | Upgrade | UBS | Neutral → Buy |
| Apr-26-23 | Initiated | Guggenheim | Neutral |
| Mar-13-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Mar-02-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-24-23 | Downgrade | SVB Securities | Market Perform → Underperform |
| Dec-19-22 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-22 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-21-22 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Sep-08-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-01-22 | Upgrade | Redburn | Sell → Neutral |
| Jan-26-22 | Upgrade | Deutsche Bank | Sell → Hold |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-21-22 | Initiated | UBS | Neutral |
| Dec-07-21 | Initiated | Cowen | Market Perform |
| Nov-09-21 | Initiated | Wolfe Research | Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Sell |
| Oct-15-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-06-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-06-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-15-21 | Reiterated | Jefferies | Hold |
| Feb-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-16-20 | Downgrade | Jefferies | Buy → Hold |
| Dec-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-09-20 | Downgrade | Needham | Buy → Hold |
| Nov-23-20 | Initiated | Wells Fargo | Equal Weight |
| Nov-17-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-08-20 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| Jul-23-20 | Initiated | SVB Leerink | Mkt Perform |
| Jul-20-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Argus | Buy |
| Jun-08-20 | Initiated | Barclays | Overweight |
| Apr-30-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-25-19 | Initiated | ROTH Capital | Buy |
| Apr-05-19 | Initiated | Chardan Capital Markets | Buy |
View All
Moderna Inc Stock (MRNA) Latest News
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? - Yahoo Finance
Vaccine Stocks Face Uncertainty Amid FDA Leadership Changes - GuruFocus
SA Asks: How will changes at FDA impact vaccine makers? (MRNA:NASDAQ) - Seeking Alpha
Moderna Options Trading: A Deep Dive into Market Sentiment - Benzinga
Edmond DE Rothschild Holding S.A. Cuts Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by AIA Group Ltd - MarketBeat
3,940,194 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Norges Bank - MarketBeat
Moderna (NASDAQ:MRNA) Sets New 52-Week LowWhat's Next? - MarketBeat
Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month - Yahoo Finance
Moderna (NASDAQ:MRNA) Shares Gap DownWhat's Next? - MarketBeat
Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy? - Yahoo Finance
Moderna Stock Falls After Resignation of FDA Official - Nasdaq
FDA Leadership Changes Impact Moderna and Other Biotech Stocks (MRNA) - GuruFocus
Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins - Yahoo
UniSuper Management Pty Ltd Purchases 20,862 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Corebridge Financial Inc. Sells 28,775 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Trims Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Watch These Moderna Price Levels as Stock Sinks to 5-Year Low - Yahoo
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ
Moderna stock drops after FDA vaccine chief resigns - Sherwood News
8 Best Gene-Editing Stocks to Buy - Insider Monkey
FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (MRNA) - Seeking Alpha
These Stocks Moved the Most Today: Tesla, CoreWeave, Nvidia, Palantir, Moderna, Boeing, and More - Barron's
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official - Investopedia
Moderna (MRNA) Stock Trades Down, Here Is Why - Yahoo Finance
U.S. Markets Finished Mixed Monday As Discover Finl Svcs Led, Moderna Lagged - Barron's
Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
Moderna's Options Frenzy: What You Need to Know - Benzinga
Why Moderna Stock Is Plummeting Today - Yahoo Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' - Fortune
Moderna, Rocket, Hut 8: Market Minute - Yahoo Finance
Top Stock Movers Now: Tesla, Nvidia, Moderna, and More - Yahoo Finance
Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' - Investopedia
Moderna, Novavax Drop After FDA’s Top Vaccine Official Exits - Bloomberg.com
Fiery Resignation of Top FDA Official Sparks Biotech Stock Selloff - Barron's
Moderna and other vaccine stocks fall after a top FDA official quits - Yahoo Finance
Tesla, Moderna Lead Market Cap Stock Movers on Monday By Investing.com - Investing.com Australia
Tesla, Moderna Lead Market Cap Stock Movers on Monday - Investing.com India
Brookline maintains Buy on Moderna stock, price target at $212 By Investing.com - Investing.com UK
Moderna, biotech stocks slide following resignation of FDA official Peter Marks - Yahoo Finance
The Magnificent 7, automakers, Moderna, Warner Bros. Discovery, U.S. Bancorp: Stocks to watch today - Yahoo Finance
Moderna stock hits 52-week low at $28.75 amid market challenges By Investing.com - Investing.com South Africa
Moderna stock hits 52-week low at $28.75 amid market challenges - Investing.com
Moderna shares drop amid FDA leadership change - Yahoo Finance
Peering Into Moderna's Recent Short Interest - Benzinga
Pharma stocks sink after ouster of top FDA vaccine regulator - Reuters
Moderna's RSV Vaccine Receives Approval in Australia - Marketscreener.com
Vaccine Makers Plunge After FDA Biologics Head Marks Steps Down - Bloomberg.com
Moderna’s RSV vaccine gets Australian approval for older adults - Investing.com Australia
Moderna Inc Stock (MRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):